Search by Drug Name or NDC

    NDC 59651-0436-01 Digoxin 0.0625 mg/1 Details

    Digoxin 0.0625 mg/1

    Digoxin is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is DIGOXIN.

    Product Information

    NDC 59651-0436
    Product ID 59651-436_2bcd56ee-4497-4b8d-84db-a1470c77827b
    Associated GPIs 31200010000303
    GCN Sequence Number 013079
    GCN Sequence Number Description digoxin TABLET 62.5 MCG ORAL
    HIC3 A1A
    HIC3 Description DIGITALIS GLYCOSIDES
    GCN 00130
    HICL Sequence Number 000004
    HICL Sequence Number Description DIGOXIN
    Brand/Generic Generic
    Proprietary Name Digoxin
    Proprietary Name Suffix n/a
    Non-Proprietary Name Digoxin
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 0.0625
    Active Ingredient Units mg/1
    Substance Name DIGOXIN
    Labeler Name Aurobindo Pharma Limited
    Pharmaceutical Class Cardiac Glycoside [EPC], Cardiac Glycosides [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA214982
    Listing Certified Through 2024-12-31

    Package

    NDC 59651-0436-01 (59651043601)

    NDC Package Code 59651-436-01
    Billing NDC 59651043601
    Package 100 TABLET in 1 BOTTLE (59651-436-01)
    Marketing Start Date 2022-02-08
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 2bcd56ee-4497-4b8d-84db-a1470c77827b Details

    Revised: 2/2022